TPD52 and invasive breast carcinoma: The abundance of T cells, cytotoxic lymphocytes, B cells, NK cells, monocytes, neutrophils and myeloid dendritic cells was significantly lower in BRCA patients with high TPD52 expression (Figure 5A).